Synthetic Uses of Cycloreversion Processes
(CH3). Anal. Calcd for C17H21NO5S: C, 58.10; H, 6.02; N, 3.99;
S, 9.12. Found: C, 58.13; H, 5.91; N, 4.15; S, 9.43.
place only when two electron-withdrawing groups were
bonded to C8b.
(R3,SS)-3-Ethoxy-8b-[(4-methylphenyl)sulfinyl-
3a,6,7,8,8a,8b-hexahydrofuro[3,4-d]pyrrolo[1,2-b]isoxazol-
1(3H)-ones (5b). Compound 5b was obtained as a mixture of
anti-5b-exo and anti-5b-endo from (R5,SS)-5-ethoxy-3-[(4-methyl-
phenyl)sulfinylfuran-2(5H)-one (2b) and 4. The experimental
conditions, the stereoisomer ratio, and the obtained yields are
shown in Table 2. The products were separated by column
chromatography (hexane/ethyl acetate, 3:1).
Conclusion
We have studied the reactions of sulfinyl furanones 2a
and 2b with cyclic and acyclic nitrones (4 and 6). The
sulfinyl group significantly enhances the dipolarophilic
reactivity of the furanones, it is the main responsible for
the endo/exo selectivity, and modulates the facial selec-
tivity imposed by the 5-alkoxy substituent. The adducts
suffer an easy cycloreversion, which determines signifi-
cant changes in the composition of the equilibria depend-
ing on the experimental conditions. As these changes
increase or invert the stereoselectivity, they can be used
with synthetic purposes. Finally, we have established
that cycloreversion must be expected for those isoxazo-
lidines bearing two electron withdrawing groups at C4.
(R3,S3a,S8a,R8b,SS)-anti-5b-exo. Colorless oil. [R]20D ) -52.8
1
(c 1.4, CHCl3). IR (CHCl3): 1765, 1597, 1352, 1083, 1057. H
NMR (200 MHz) δ: 7.58 and 7.28 (AA′BB′ system, 4H), 5.35
(s, 1H), 4.83 (s, 1H), 4.06 (dd, 1H, J ) 8.1 and 8.9), 3.40 (m,
3H), 3.02 (m, 1H), 2.58 (m, 1H); 2.40 (s, 3H), 2.22 (m, 1H),
2.06 (m, 1H), 1.89 (m, 1H), 0.99 (t, 3H, J ) 7.0). 13C NMR (50.3
MHz) δ: 171.2 (C), 143.0 (C), 135.4 (C), 129.4 (CH), 126.4 (CH),
108.1 (CH), 83.0 (C), 78.3 (CH), 74.2 (CH), 65.6 (CH2), 55.0
(CH2), 24.7 (CH2), 24.1 (CH2), 21.4 (CH3), 14.5 (CH3). Anal.
Calcd for C17H21NO5S: C, 58.10; H, 6.02; N, 3.99; S, 9.12.
Found: C, 57.45; H, 6.12; N, 4.13; S, 8.65.
(R3,S3a,R8a,R8b,SS)-anti-5b-endo. White solid. Mp: 103-
104 °C. [R]20 ) +81.2 (c 1.0, CHCl3). IR (KBr): 1765, 1595,
Experimental Section
D
1361, 1086, 1063. 1H NMR (200 MHz) δ: 7.55 and 7.31 (AA′BB′
system, 4H), 5.21 (s, 1H), 4.66 (s, 1H), 4.31 (m, 1H), 3.37-
3.06 (m, 4H), 2.41 (s, 3H), 2.22-1.79 (m, 4H), 0.84 (t, 3H, J )
7.0). 13C NMR (50.3 MHz) δ: 170.3 (C), 142.8 (C), 135.1 (C),
129.7 (CH), 125.6 (CH), 105.1 (CH), 83.7 (C), 82.3 (CH), 72.6
(CH), 65.6 (CH2), 55.6 (CH2), 26.1 (CH2), 23.6 (CH2), 21.4 (CH3),
14.2 (CH3). Anal. Calcd for C17H21NO5S: C, 58.10; H, 6.02; N,
3.99; S, 9.12. Found: C, 58.15; H, 5.70; N, 3.74; S, 8.86.
(S6,SS)-6-Ethoxy-2-methyl-3a-[(4-methylphenyl)sulfinyl]-
3-phenyl-3,3a,6,6a-tetrahydrofuro[3,4-d]isoxazol-4(2H)-
ones (7a). Compound 7a was obtained as a mixture of anti-
7a-endo and syn-7a-endo from (S5,SS)-5-ethoxy-3-[(4-methyl-
phenyl)sulfinyl]furan-2(5H)-one (2a) and nitrone 6, following
the general procedure. The stereoisomer ratio and the obtained
yields are indicated in Table 3. The products were isolated by
column chromatography (hexane/ethyl acetate, 3:1).
Cycloadditions of Nitrones. General Procedure. A
solution of furanone 2a or 2b (1.21 mmol) and nitrone 4 (1.82
mmol in 15 mL) or 6 (4.84 mmol in 16 mL) in the solvent
indicated in Tables 1-4 was stirred under argon at the
temperature and for the time indicated in Tables 1-4. The
1
reaction was monitored by TLC and H NMR. After comple-
tion, the solvent was removed at reduced pressure. The
adducts were isolated by column chromatography with the
eluent indicated in each case.
(S3,SS)-3-Ethoxy-8b-[(4-methylphenyl)sulfinyl]-
3a,6,7,8,8a,8b-hexahydrofuro[3,4-d]pyrrolo[1,2-b]isoxazol-
1(3H)-ones (5a). Compound 5a was obtained from (S5,SS)-5-
ethoxy-3-[(4-methylphenyl)sulfinyl]furan-2(5H)-one (2a) and
nitrone 4 (see Table 1) after 1 h of reaction time in chloroform
at room temperature in 86% combined yield. The stereoisomers
were separated by column chromatography (hexane/ethyl
acetate, 3:2).
(S3,S3a,S6,R6a,SS)-anti-7a-endo. White solid. Mp: 56-58
°C. [R]20D ) +188.0 (c 0.5, CHCl3). IR (KBr): 1778, 1595, 1083,
1
(S3,R3a,R8a,S8b,SS)-anti-5a-exo. White solid. Mp: 86-87 °C.
1051. H NMR (300 MHz) δ: 7.75 and 7.34 (AA′BB′ system,
[R]20 ) +219.7 (c 1.0, CHCl3). IR (Nujol): 1770, 1595, 1460,
4H), 7.22 (m, 3H), 6.89 (m, 2H), 5.64 (d, 1H, J ) 2.2), 4.98 (d,
1H, J ) 2.2), 3.88 (m, 1H), 3.73 (s, 1H), 3.70 (m, 1H), 2.47 (s,
3H), 2.45 (s, 3H), 1.25 (t, 3H, J ) 7.1). 13C NMR (75.5 MHz) δ:
168.2 (C), 143.2 (C), 135.2 (C), 132.1 (C), 129.7 (CH), 129.0
(CH), 128.3 (CH), 126.5 (CH), 106.5 (CH), 83.2 (CH), 81.3 (C),
76.8 (CH), 66.3 (CH2), 42.1 (CH3), 21.4 (CH3), 14.7 (CH3). Anal.
Calcd for C21H23NO5S: C, 62.82; H, 5.77; N, 3.49; S, 7.99.
Found: C, 62.90; H, 5.78; N, 3.44; S, 8.33.
D
1090, 1070. 1H NMR (200 MHz) δ: 7.60 and 7.25 (AA′BB′
system, 4H), 5.18 (s, 1H), 4.25 (s, 1H), 3.84 (dd, 1H, J ) 7.6
and 9.1), 3.34 (m, 1H), 3.31 (q, 2H, J ) 7.1), 2.95 (m, 1H), 2.40-
2.07 (m, 3H), 2.34 (s, 3H), 1.95-1.83 (m, 1H), 0.88 (t, 3H, J )
7.1). 13C NMR (50.3 MHz) δ: 170.0 (C), 143.2 (C), 135.4 (C),
129.7 (CH), 126.2 (CH), 106.5 (CH), 81.2 (CH), 79.6 (C), 73.9
(CH), 65.4 (CH2), 55.2 (CH2), 24.8 (CH2), 24.3 (CH2), 21.4 (CH3),
14.4 (CH3). Anal. Calcd for C17H21NO5S: C, 58.10; H, 6.02; N,
3.99; S, 9.12. Found: C, 57.78; H, 5.66; N, 4.01; S, 8.82.
(R3,R3a,S6,S6a,SS)-syn-7a-endo. White solid. Mp: 122-124
°C. [R]20D ) -41.6 (c 0.25, CHCl3). IR (KBr): 1773, 1595, 1495,
1073, 1053. 1H NMR (300 MHz) δ: 7.50 and 7.34 (AA′BB′
system, 4H), 7.46 (m, 5H), 4.87 (d, 1H, J ) 5.1), 4.28 (s, 1H),
4.25 (d, 1H, J ) 5.1), 3.82 (m, 1H), 3.57 (m, 1H), 2.69 (s, 3H),
2.42 (s, 3H), 1.23 (t, 3H, J ) 7.1). 13C NMR (75.5 MHz) δ: 166.9
(C), 143.4 (C), 134.9 (C), 131.4 (C), 130.3 (CH), 129.2 (CH),
128.6 (CH), 128.5 (CH), 124.6 (CH), 103.1 (CH), 84.4 (C), 76.5
(CH), 74.0 (CH), 67.3 (CH2), 43.1 (CH3), 21.4 (CH3), 14.6 (CH3).
Anal. Calcd for C21H23NO5S: C, 62.82; H, 5.77; N, 3.49; S, 7.99.
Found: C, 62.60; H, 5.42; N, 3.48; S, 7.60.
(R6,SS)-6-Ethoxy-2-methyl-3a-[(4-methylphenyl)sulfinyl]-
3-phenyl-3,3a,6,6a-tetrahydrofuro[3,4-d]isoxazol-4(2H)-
ones (7b). Compound 7b was obtained following the general
procedure from (R5,SS)-5-ethoxy-3-[(4-methylphenyl)sulfinyl]-
furan-2(5H)-one (2b) and 6 as mixtures of anti-7b-endo and
anti-7b-exo in the ratio and yields indicated in Table 4. The
adducts were purified by column chromatography (hexane/
ethyl acetate, 7:1).
(S3,R3a,S8a,S8b,SS)-anti-5a-endo. White solid. Mp: 74-75
°C. [R]20D ) +56.8 (c 1.0, CHCl3). IR (Nujol): 1775, 1595, 1460,
1082, 1057. 1H NMR (200 MHz) δ: 7.64 and 7.36 (AA′BB′
system, 4H), 5.36 (s, 1H), 4.72 (s, 1H), 4.27 (m, 1H), 3.74 (m,
1H), 3.61 (m, 1H), 3.22 (m, 1H), 3.05 (m, 1H), 2.45 (s, 3H),
1.90-1.65 (m, 4H), 1.17 (t, 3H, J ) 7.0). 13C NMR (50.3 MHz)
δ: 169.1 (C), 143.1 (C), 135.0 (C), 129.4 (CH), 126.0 (CH), 102.6
(CH), 84.4 (CH), 78.9 (C), 68.4 (CH), 65.6 (CH2), 55.9 (CH2),
25.6 (CH2), 23.6 (CH2), 21.4 (CH3), 14.4 (CH3). Anal. Calcd for
C17H21NO5S: C, 58.10; H, 6.02; N, 3.99; S, 9.12. Found: C,
58.08; H, 5.71; N, 3.80; S, 9.56.
(S3,S3a,R8a,R8b,SS)-syn-5a-endo. White solid. Mp: 89-90
°C. [R]20D ) +256.6 (c 1.0, CHCl3). IR (Nujol): 1760, 1595, 1460,
1080, 1055. 1H NMR (200 MHz) δ: 7.55 and 7.35 (AA′BB′
system, 4H), 5.00 (d, 1H, J ) 4.3), 4.68 (d, 1H, J ) 4.3), 4.09
(m, 1H), 3.78 (m, 1H), 3.59 (m, 1H), 3.32 (m, 1H), 3.05 (m,
1H), 2.43 (s, 3H), 2.11-1.68 (m, 4H), 1.19 (t, 3H, J ) 7.1). 13
C
NMR (50.3 MHz) δ: 167.5 (C), 143.6 (C), 135.0 (C), 130.0 (CH),
125.1 (CH), 101.9 (CH), 83.6 (C), 80.1 (CH), 71.1 (CH), 67.9
(CH2), 55.6 (CH2), 25.2 (CH2), 23.6 (CH2), 21.5 (CH3), 14.6
(R3,R3a,R6,S6a,SS)-anti-7b-endo. White solid. Mp: 142-143
°C. [R]20D ) -144.0 (c 0.5, CHCl3). IR (KBr): 1773, 1594, 1493,
1082, 1051. 1H NMR (300 MHz) δ: 7.49 and 7.29 (AA′BB′
J. Org. Chem, Vol. 70, No. 22, 2005 8833